Viewing Study NCT05274633

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-05-13 @ 12:18 AM
Study NCT ID: NCT05274633
Status: COMPLETED
Last Update Posted: 2025-06-12
First Post: 2022-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Real Life Use of Ravulizumab in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Paroxysmal Nocturnal Hemoglobinuria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PIGA Gene View
None Complement-inhibitor Protein View
None CD55 View
None CD59 View
None Efficacy View
None Safety View
None Patient Registry View